Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson’s Disease
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Neural Plasticity
- Vol. 2013 (1) , 587418
Abstract
Parkinson’s disease (PD) is a chronic, degenerative neurological disorder that is estimated to affect at least 1 million individuals in the USA and over 10 million worldwide. It is thought that the loss of neurons and development of inclusion bodies occur gradually over decades until they progress to the point where ~60% of the dopamine neurons are lost and patients present with motor dysfunction. At present, it is not clear what causes this progression, and there are no current therapies that have been successful in preventing PD progression. Although there are many hypotheses regarding the mechanism of PD progression, neuroinflammation may be a major contributor to PD pathogenesis. Indeed, activated microglia and subsequent neuroinflammation have been consistently associated with the pathogenesis of PD. Thus, interference with this process could provide a means of neuroprotection in PD. This review will discuss the potential of targeting microglia to reduce neuroinflammation in PD. Further, we discuss the potential of microglial ion channels to serve as novel targets for neuroprotection in PD.Keywords
Funding Information
- National Institutes of Health (P30ES005022)
- National Institutes of Health (R01ES015991)
- National Institutes of Health (U01NS079249)
- National Institutes of Health (R21NS072097)
- National Institutes of Health (P30ES005022)
- National Institutes of Health (R01ES015991)
- National Institutes of Health (U01NS079249)
- National Institutes of Health (R21NS072097)
- National Institutes of Health (P30ES005022)
- National Institutes of Health (R01ES015991)
- National Institutes of Health (U01NS079249)
- National Institutes of Health (R21NS072097)
- National Institutes of Health (P30ES005022)
- National Institutes of Health (R01ES015991)
- National Institutes of Health (U01NS079249)
- National Institutes of Health (R21NS072097)
This publication has 79 references indexed in Scilit:
- HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic ActivityPLOS ONE, 2013
- NADPH oxidases: novel therapeutic targets for neurodegenerative diseasesTrends in Pharmacological Sciences, 2012
- The voltage-gated proton channel Hv1 enhances brain damage from ischemic strokeNature Neuroscience, 2012
- The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's diseaseNeurobiology of Disease, 2011
- Inhibition of Na + /H + Exchanger Isoform 1 Is Neuroprotective in Neonatal Hypoxic Ischemic Brain InjuryAntioxidants & Redox Signaling, 2011
- Reactive microgliosis: extracellular μ-calpain and microglia-mediated dopaminergic neurotoxicityBrain, 2010
- Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survivalNeuroToxicology, 2009
- Hv1 proton channels are required for high-level NADPH oxidase-dependent superoxide production during the phagocyte respiratory burstProceedings of the National Academy of Sciences, 2009
- Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degenerationNeurobiology of Disease, 2007
- A voltage-gated proton-selective channel lacking the pore domainNature, 2006